HUM-MOLGEN events: Chronic Lung diseases

HUM-MOLGEN -> Events -> Meetings and Conferences

May 21, 2001

Institut Pasteur, Paris, France
June 27-29, 2001

June 27, 2001
Satellite « RELEVANCE FOR ALLERGIC AND NON ALLERGIC LUNG DISEASES OF OUTDOOR AND INDOOR AIR POLLUTION » chaired by :F. Marano (F) and G. Peltre (F)
INTRODUCTION • R. Niessner (G): What is air pollution? • D. Diaz-Sanchez (USA): The impact of particulate pollution on lung diseases.
EPIDEMIOLOGY OF POLLUTION • F. Kauffmann (F): Environmental factors of obstructive pulmonary diseases in adults • E. von Mutius (G): Epidemiology of asthma with respect to pollution.
DIESEL, LPS, POLLENS • F. Marano (F): Molecular mechanisms of the inflammatory response trigger by diesel exhaust particles in human airways • B. Wallaert (F) Synergistic effects of diesel exhausts and allergen on allergic inflammation • R. Pauwells (B) Endotoxin and bronchial asthma • F. Spieksma (The Netherlands) Exposure to pollen: European surveys.

June 28, 2001
GENERAL INTRODUCTION • J. Samet (USA): Using epidemiology to find the causes of chronic lung diseases • I. Hall (UK): Genetics of chronic lung diseases • M. Vignola (I) • Histopathology of chronic lung diseases.
CELL-CELL AND CELL-PATHOGEN INTERACTIONS • W. Mc Nee (UK): Oxidants/antioxidants in chronic obstructive pulmonary disease • S. Shapiro (USA): Role of elastases in COPD • R. Pabst (D): Intraepithelial lymphocytes in the lung - only one of several lymphocyte compartments • R. Stockley (UK): Contribution of neutrophils to the pathogenesis of COPD.
EPITHELIAL INJURY, REPAIR AND REMODELING • J. Hogg (CDN): The role of viral infection in the pathogenesis of chronic obstructive lung disease • E. Puchelle (F): Airway epithelial repair and regeneration • K. B. Adler (USA): Mechanisms of secretion in human airways • R. Panettieri (USA): Remodeling and airway smooth muscle cell function

June 29, 2001
ACUTE AND CHRONIC LUNG INFLAMMATION • C. Haslett (UK): Apoptosis and the resolution of lung inflammation • G. Laurent (UK): Molecular mechanisms of pulmonary fibrosis • A. Brody (USA): Growth factor expression at the alveolar level. • Jack Elias (USA): Transgenic modeling of alveolar enlargement and COPD • B. B. Vargaftig (F): Lung disease modeling with LPS and environmental challenges.
MECHANISMS AND NOVEL DRUG STRATEGIES • J. Garcia (USA): Update in advanced lung disease: What's new? What's working? • P. Barnes (UK): Role of glucocorticosteroids in COPD • T. J. Torphy (USA): Will antibodies have a role in the therapy of COPD? • M. A. Lindsay (UK): P38 mitogen activated protein kinase as a potential anti-inflammatory target • D. E. Griswold (USA): The role of interleukin-8 and CXCR2 in inflammatory lung disease • M.-P. Pruniaux (F): Therapeutic potential of phosphodiesterase 4 inhibitors in chronic lung diseases • D. Hay (USA): Strategies and challenges in the search for novel molecular targets for chronic inflammatory lung disease.

Organized by:

Institut Pasteur

Invited Speakers:

June 27, 2001
Satellite « RELEVANCE FOR ALLERGIC AND NON ALLERGIC LUNG DISEASES OF OUTDOOR AND INDOOR AIR POLLUTION » chaired by :F. Marano (F) and G. Peltre (F)
INTRODUCTION • R. Niessner (G): What is air pollution? • D. Diaz-Sanchez (USA): The impact of particulate pollution on lung diseases.
EPIDEMIOLOGY OF POLLUTION • F. Kauffmann (F): Environmental factors of obstructive pulmonary diseases in adults • E. von Mutius (G): Epidemiology of asthma with respect to pollution.
DIESEL, LPS, POLLENS • F. Marano (F): Molecular mechanisms of the inflammatory response trigger by diesel exhaust particles in human airways • B. Wallaert (F) Synergistic effects of diesel exhausts and allergen on allergic inflammation • R. Pauwells (B) Endotoxin and bronchial asthma • F. Spieksma (The Netherlands) Exposure to pollen: European surveys.

June 28, 2001
GENERAL INTRODUCTION • J. Samet (USA): Using epidemiology to find the causes of chronic lung diseases • I. Hall (UK): Genetics of chronic lung diseases • M. Vignola (I) • Histopathology of chronic lung diseases.
CELL-CELL AND CELL-PATHOGEN INTERACTIONS • W. Mc Nee (UK): Oxidants/antioxidants in chronic obstructive pulmonary disease • S. Shapiro (USA): Role of elastases in COPD • R. Pabst (D): Intraepithelial lymphocytes in the lung - only one of several lymphocyte compartments • R. Stockley (UK): Contribution of neutrophils to the pathogenesis of COPD.
EPITHELIAL INJURY, REPAIR AND REMODELING • J. Hogg (CDN): The role of viral infection in the pathogenesis of chronic obstructive lung disease • E. Puchelle (F): Airway epithelial repair and regeneration • K. B. Adler (USA): Mechanisms of secretion in human airways • R. Panettieri (USA): Remodeling and airway smooth muscle cell function

June 29, 2001
ACUTE AND CHRONIC LUNG INFLAMMATION • C. Haslett (UK): Apoptosis and the resolution of lung inflammation • G. Laurent (UK): Molecular mechanisms of pulmonary fibrosis • A. Brody (USA): Growth factor expression at the alveolar level. • Jack Elias (USA): Transgenic modeling of alveolar enlargement and COPD • B. B. Vargaftig (F): Lung disease modeling with LPS and environmental challenges.
MECHANISMS AND NOVEL DRUG STRATEGIES • J. Garcia (USA): Update in advanced lung disease: What's new? What's working? • P. Barnes (UK): Role of glucocorticosteroids in COPD • T. J. Torphy (USA): Will antibodies have a role in the therapy of COPD? • M. A. Lindsay (UK): P38 mitogen activated protein kinase as a potential anti-inflammatory target • D. E. Griswold (USA): The role of interleukin-8 and CXCR2 in inflammatory lung disease • M.-P. Pruniaux (F): Therapeutic potential of phosphodiesterase 4 inhibitors in chronic lung diseases • D. Hay (USA): Strategies and challenges in the search for novel molecular targets for chronic inflammatory lung disease.

Deadline for Abstracts:

April 30, 2001

Registration:

Industrial : 6 000 FF VAT excluded
Academic : 3 000 FF VAT excluded

E-mail:

euroconf@pasteur.fr

Posted by:

Ludovic Drye

Host:

cache.pasteur.fr